Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome

NCT04366063 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Covid-19

Interventions

BIOLOGICAL: Cell therapy protocol 1
BIOLOGICAL: Cell therapy protocol 2

Sponsor

Royan Institute

Collaborators

[object Object]
[object Object]